吸入一氧化氮市場報告：2030 年趨勢、預測與競爭分析

吸入一氧化氮的趨勢和預測

全球吸入一氧化氮市場的未來前景廣闊，新生兒呼吸治療、氣喘和慢性阻塞性肺病、急性呼吸窘迫症候群、瘧疾治療和結核病治療市場充滿機會。預計到 2030 年，全球吸入一氧化氮市場將達到 11 億美元，2024 年至 2030 年複合年成長率為 5.1%。該市場的主要促進因素是呼吸系統疾病和其他相關疾病的日益流行，以及持續的研發活動。

• 根據產品類型，Lucintel 預計輸送系統將在預測期內實現高速成長，因為緊湊型攜帶式輸送系統的推出將使各種醫療保健應用中的一氧化氮治療變得更加容易，我預測這一目標將會實現。
• 在這個使用類別中，由於菸草消費量的增加，導致氣喘和慢性阻塞性肺病的症狀，預期氣喘和慢性阻塞性肺病的成長最快。
• 從地區來看，由於慢性阻塞性肺病和氣喘等疾病的迅速增加、人口老齡化的加劇以及大公司在該地區的存在，預計北美在預測期內將出現最高的成長。

吸入一氧化氮市場的策略性成長機會

吸入一氧化氮市場在各種應用中提供了策略成長機會。值得注意的機會包括技術進步、適應症臨床使用的增加以及對有效呼吸治療的需求不斷成長。

• 擴展到新興市場：由於對先進呼吸療法的需求不斷增加，擴展到新興市場代表著成長潛力。這些地區提供了促進和改善吸入一氧化氮治療的可近性的機會。
• 開發先進的輸送系統：新型、精準、舒適的輸送系統可以提供更好的治療效果，吸引更多的客戶。創新技術提供了在蓬勃發展的吸入一氧化氮市場中獲得競爭優勢的機會。
• 開拓新的臨床應用：擴大吸入一氧化氮治療肺動脈高壓和慢性呼吸道疾病等疾病的地理範圍，提供了成長機會並增加了治療價值。
• 吸入一氧化氮用於遠端和協調護理的經濟性：將硝酸鹽血管擴張器光學元件與劑量測定工具相結合，可以實現遠端患者管理和健康資料收集。這種整合將提高護理品質並支持市場成長。
• 降低成本的機會：開發負擔得起的一氧化氮吸入系統可以滿足資源有限地區對呼吸治療的需求。更實惠的產品將增加市場佔有率並鼓勵吸入一氧化氮的廣泛使用。

擴展到新的地區、開發新的輸送設備、擴大臨床應用、與數位健康平台整合以及專注於具有成本效益的解決方案都是策略性成長機會。這些努力預計將有助於市場成長並提高吸入一氧化氮療法的有效性。

吸入一氧化氮市場的促進因素與挑戰

吸入一氧化氮市場主要受到新技術、法規結構變化、社會健康狀況變化等影響。這些因素推動了市場成長，並影響了吸入一氧化氮療法的採用和發展。

推動吸入一氧化氮市場的因素是：

• 技術發展：遠端檢測和遠端患者監護的進步將使遠端醫療解決方案更加有效，並使吸入一氧化氮療法能夠納入此類系統。透過向消費者提案新設備，我們將能夠提供更好的醫療服務。
• 呼吸系統疾病的增加：呼吸系統疾病盛行率的增加增加了對吸入一氧化氮等有效治療方法的需求。這一趨勢可能會促進經濟的永續性，並促進吸入一氧化氮領域新治療方法和技術的發展。
• 監管支援：支持性法律規範有助於在吸入一氧化氮市場引入新產品和技術。順利的產品核可和有吸引力的創新有助於市場成長和新產品開發。
• 醫療保健設施的成長：醫療保健設施的擴張，尤其是在發展中地區，增加了吸入一氧化氮療法的供應和接受度。由於醫療保健服務和可近性的改善，這將對市場成長產生積極影響。
• 快速、成功治療的重要性：早期診斷和成功治療有助於開發吸入一氧化氮等先進治療方法。早期療育可以改善患者的治療效果並支持市場成長。

吸入一氧化氮市場的挑戰包括：

• 高成本：吸入一氧化氮技術的成本過高，特別是對於低收入國家而言，限制了其廣泛使用。解決成本問題對於擴大吸入一氧化氮治療的可近性至關重要。
• 監管障礙：監管問題可能減緩新產品的開發和市場進入。在將新技術引入吸入一氧化氮市場之前，公司必須克服這些障礙。
• 認知和訓練有限：認知和訓練有限可能會影響吸入一氧化氮治療的有效管理。教育負責人正確使用吸入一氧化氮對於改善病患的治療效果至關重要。

研究活動、針對呼吸困難的新設備的推出、有利的法規、醫療保健系統的改進以及預防性治療等市場促進因素正在推動吸入一氧化氮市場的發展。市場也面臨與高成本、監管限制和缺乏意識相關的挑戰，必須克服這些挑戰以支持市場和患者照護。平衡這些促進因素和挑戰對於擴大吸入一氧化氮治療並擴大其在呼吸醫學中的作用至關重要。

目錄

第1章執行摘要

第2章全球吸入一氧化氮市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球吸入一氧化氮市場趨勢（2018-2023）與預測（2024-2030）
• 全球吸入一氧化氮市場：依產品類型
  • 氣體
  • 輸送系統
• 吸入一氧化氮的全球市​​場：按應用分類
  • 新生兒呼吸治療
  • 氣喘及慢性阻塞性肺病
  • 急性呼吸頻率綜合症
  • 瘧疾治療
  • 結核病治療
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 按地區分類的全球可吸入一氧化氮市場
• 北美吸入一氧化氮市場
• 歐洲吸入一氧化氮市場
• 亞太地區吸入一氧化氮市場
• 其他地區吸入一氧化氮市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 按產品類型分類的全球吸入一氧化氮市場成長機會
  • 全球吸入一氧化氮市場成長機會（按應用）
  • 按地區分類的全球吸入一氧化氮市場成長機會
• 全球吸入一氧化氮市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 全球吸入一氧化氮市場產能擴張
  • 全球吸入一氧化氮市場的併購和合資企業
  • 認證和許可

第7章主要企業概況

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are the increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

• Lucintel forecasts that, within the product type category, delivery systems are expected to witness higher growth over the forecast period due to the introduction of the compact and portable delivery system, which enables easier administration of nitric oxide therapy in various healthcare applications.
• Within this application category, asthma and COPD are expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the surging incidence of diseases like COPD and asthma, the increasing aging population, and the presence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Inhaled Nitric Oxide Market

Inhaled nitric oxide is driving new developments and influencing the growth of the modality. These trends highlight advancements in technology, expanding applications, and increasing practices in healthcare.

• Improved Delivery Devices: New delivery systems allow for more accurate dosing and increased patient comfort. Device improvements also help maximize ileum activity, meaning the therapy could be integrated into neonatal and adult care by clinicians.
• Expanding Clinical Uses: The indications for inhaled nitric oxide treatment are expanding to ARDS, respiratory complications of COVID-19, and pulmonary hypertension. Research has shown that inhaled nitric oxide is effective in treating various respiratory illnesses.
• Synergy with Other Development Approaches: The use of conventional therapeutics such as mechanized respiratory support or pharmacological agents enhances inhaled nitric oxide therapy, playing a key role in patient management. This integrated approach improves therapy outcomes and helps manage more complex respiratory conditions.
• Focus on Cost-Effectiveness: While the benefits of inhaled nitric oxide therapy are gaining credibility, efforts are also being made to make delivery systems more affordable. Inexpensive solutions bring the therapy closer to patients, allowing a broader group to benefit from treatment.
• Advances in Research and Development: Ongoing research is advancing inhaled nitric oxide technology and broadening its use in medicine. With these efforts in R&D, it is reasonable to assume that other therapies are improving, including those where inhaled nitric oxide plays a role.

As demonstrated, emerging trends such as improved delivery mechanisms, wider clinical use, synergy with other therapies, emphasis on technological efficiency, and increased research activities are transforming the inhaled nitric oxide market. These trends are driving novel designs and improvements in treatments, expanding the scope of action, and enhancing the quality of patient care.

Recent Developments in the Inhaled Nitric Oxide Market

Recent trends in the inhaled nitric oxide market reflect advancements in technology, clinical applications, and patient treatment. These developments are shaping the industry's future in respiratory therapies.

• New Inhaled Nitric Oxide Delivery Systems: New delivery systems ensure careful administration of inhaled nitric oxide, improving patient outcomes. Advanced device technology has been shown to enhance the effectiveness and safety of inhaled nitric oxide, making it applicable in diverse clinical settings.
• Expanded Clinical Indications: Inhaled nitric oxide is used to improve outcomes in ARDS and acute SARS-CoV-2-induced respiratory failure. The extended use suggests that clinical evidence for improved therapeutic response has accumulated for a range of respiratory conditions.
• Cost-Effective Solutions: Affordable inhaled nitric oxide solutions improve accessibility, particularly in low-resource settings. These innovations encourage wider use of inhaled nitric oxide therapy, helping bridge gaps in respiratory care.
• Integration with Telemedicine: Telemedicine integration enables remote monitoring and management of inhaled nitric oxide therapy. This improves the quality of care by allowing necessary changes and communication throughout treatment.
• Increased Research and Clinical Trials: The growing number of research studies and clinical trials seeks to fully understand the benefits and uses of inhaled nitric oxide. These initiatives stimulate innovation and help create new treatment modalities and indications.

Recent developments such as new delivery systems, expanded clinical indications, cost-effective solutions, telemedicine integration, and increased research are significantly impacting the inhaled nitric oxide market. These factors enhance the efficiency, availability, and utilization of inhaled nitric oxide therapy.

Strategic Growth Opportunities for Inhaled Nitric Oxide Market

The inhaled nitric oxide market offers strategic growth opportunities in various applications. Notable opportunities include technological advancements, the growing clinical use of indications, and the rising need for efficient respiratory therapies.

• Expanding into Emerging Markets: Expanding into emerging markets presents growth potential due to the increasing demand for advanced respiratory therapies. These regions offer opportunities to promote inhaled nitric oxide therapy and improve accessibility.
• Developing Advanced Delivery Systems: New, precise, and comfortable delivery systems can lead to better treatment outcomes and attract more customers. Innovative technologies present opportunities for competitive advantage in the booming inhaled nitric oxide market.
• Exploring New Clinical Applications: Expanding the geographical use of inhaled nitric oxide for conditions such as pulmonary hypertension and chronic respiratory diseases offers growth opportunities and enhances the therapeutic value of the treatment.
• Economics of Inhaled Nitric Oxide for Remote and Connected Care: The use of nitro vasodilator optics combined with dosimetry tools allows remote patient management and health data capture. This integration improves care quality and supports market growth.
• Cost Reduction Opportunities: Developing affordable inhaled nitric oxide delivery systems responds to the demand for respiratory therapies in resource-limited regions. More affordable products increase market share and encourage wider use of inhaled nitric oxide.

Expanding to new geographies, developing new delivery devices, extending clinical applications, integrating with digital health platforms, and focusing on cost-effective solutions are strategic growth opportunities. These initiatives are expected to contribute to market growth and improve the effectiveness of inhaled nitric oxide therapy.

Inhaled Nitric Oxide Market Driver and Challenges

The inhaled nitric oxide market is influenced mainly by new technologies, changing regulatory frameworks, and shifts in societal health. These factors drive the market's growth and shape the adoption and development of inhaled nitric oxide therapies.

The factors responsible for driving the inhaled nitric oxide market include:

• Technological Developments: Advances in telemetry and remote patient monitoring make telehealth solutions more effective, enabling inhaled nitric oxide therapy to be integrated into such systems. Public feedback is also valuable, as consumers suggest new devices for improved delivery and better patient care.
• Increasing Respiratory Conditions: The rising incidence of respiratory conditions increases the demand for effective therapies like inhaled nitric oxide. This trend could drive economic sustainability and enhance the development of new treatments and technologies in the inhaled nitric oxide sector.
• Regulatory Support: Supportive regulatory frameworks facilitate the introduction of new products and technologies in the inhaled nitric oxide market. Smooth product approvals and attraction of innovation contribute to market growth and the development of new products.
• Development of Healthcare Facilities: The expansion of healthcare facilities, especially in developing regions, increases the supply and acceptance of inhaled nitric oxide therapy. This positively affects market growth by improving healthcare services and accessibility.
• Importance of Prompt and Successful Treatment: Early diagnosis and successful treatment drive the development of sophisticated therapies like inhaled nitric oxide. Early interventions improve patient outcomes, supporting market growth.

Challenges in the inhaled nitric oxide market are:

• High Costs: The cost of inhaled nitric oxide technology can be prohibitive, particularly for low-income countries, limiting its adoption. Addressing costs is crucial to expanding access to inhaled nitric oxide therapy.
• Regulatory Hurdles: Regulatory issues can slow the progress of new products and their market entry. Companies must overcome these hurdles to introduce new technologies in the inhaled nitric oxide market.
• Limited Awareness and Training: Limited awareness and training can affect the effective administration of inhaled nitric oxide therapy. Educating healthcare personnel on the correct use of inhaled nitric oxide is essential for better patient outcomes.

Drivers such as research activities, the introduction of new devices for respiratory difficulties, enabling regulation, healthcare system improvements, and preventive treatments are propelling the inhaled nitric oxide market. The market also faces challenges related to high costs, regulatory limitations, and a lack of awareness, which must be overcome to support the market and patient care. Achieving a balance between these drivers and challenges is essential for expanding inhaled nitric oxide therapy and broadening its role in respiratory medicine.

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Analysis by Value from 2018 to 2030]:

• Gas
• Delivery Systems

Inhaled Nitric Oxide Market by Application [Analysis by Value from 2018 to 2030]:

• Neonatal Respiratory Treatment
• Asthma and COPD
• Acute Respiratory Distress Syndrome
• Malaria Treatment
• Tuberculosis Treatment
• Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Inhaled Nitric Oxide Market

The corporate achievements in the inhaled nitric oxide market have been significant, particularly with the increase in technological advancements and understanding of its therapeutic value. Inhaled nitric oxide is primarily used to treat various respiratory disorders, enhancing oxygenation while minimizing pulmonary arterial pressure. As research and healthcare systems evolve, market trends are changing in countries like the United States, China, Germany, India, and Japan.

• United States: Recent improvements in the United States have not only focused on new formulations but also on advanced delivery systems. An important development has been FDA approvals for next-generation inhaled nitric oxide devices with improved safety and usability.
• China: In China, the inhaled nitric oxide segment has grown through the development of new treatment centers and the expansion of technology. Other trends include collaborations with international companies to introduce modern inhaled nitric oxide equipment in hospitals and research centers.
• Germany: Germany has introduced several innovations in the inhaled nitric oxide market, focusing on device safety and efficiency. Recent trends include the introduction of advanced delivery systems with better monitoring and ergonomics.
• India: The respiratory distress therapeutic market for inhaled nitric oxide is growing in India, with efforts to make this important therapy more accessible. Recent developments include the creation of affordable delivery systems, making treatment easier for individuals in both rural and urban areas.
• Japan: Japan has made strides in integrating inhaled nitric oxide into standard treatment protocols for respiratory diseases. Recent innovations include new devices with advanced features that enhance patient comfort.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inhaled Nitric Oxide Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Inhaled Nitric Oxide Market by Product Type
  • 3.3.1: Gas
  • 3.3.2: Delivery Systems
• 3.4: Global Inhaled Nitric Oxide Market by Application
  • 3.4.1: Neonatal Respiratory Treatment
  • 3.4.2: Asthma and COPD
  • 3.4.3: Acute Respiratory Distress Syndrome
  • 3.4.4: Malaria Treatment
  • 3.4.5: Tuberculosis Treatment
  • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Inhaled Nitric Oxide Market by Region
• 4.2: North American Inhaled Nitric Oxide Market
  • 4.2.1: North American Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.3: European Inhaled Nitric Oxide Market
  • 4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.4: APAC Inhaled Nitric Oxide Market
  • 4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.5: ROW Inhaled Nitric Oxide Market
  • 4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
  • 6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
• 6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Air Liquide Healthcare
• 7.2: BOC Healthcare
• 7.3: Matheson Tri-Gas
• 7.4: Merck
• 7.5: Mallinckrodt Pharmaceuticals
• 7.6: Nu-Med Plus
• 7.7: Perma Pure